Your browser doesn't support javascript.
loading
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial.
Lung, Thomas; Jan, Stephen; de Silva, H Asita; Guggilla, Rama; Maulik, Pallab K; Naik, Nitish; Patel, Anushka; de Silva, Arjuna P; Rajapakse, Senaka; Ranasinghe, Gotabhaya; Prabhakaran, Dorairaj; Rodgers, Anthony; Salam, Abdul; Selak, Vanessa; Stepien, Sandrine; Thom, Simon; Webster, Ruth; Lea-Laba, Tracey.
Affiliation
  • Lung T; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Electronic address: tlung@georgeinstitute.org.au.
  • Jan S; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • de Silva HA; Clinical Trials Unit, Department of Pharmacology, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
  • Guggilla R; Department of Population Medicine and Civilization Diseases Prevention, Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English, Medical University of Bialystok, Bialystok, Poland.
  • Maulik PK; The George Institute for Global Health, University of New South Wales, New Delhi, India; The George Institute for Global Health, University of Oxford, Oxford, UK.
  • Naik N; All India Institute of Medical Sciences, New Delhi, India.
  • Patel A; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • de Silva AP; Department of Medicines, Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
  • Rajapakse S; Department of Medicines, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
  • Ranasinghe G; Institute of Cardiology, National Hospital of Sri Lanka, Colombo, Sri Lanka.
  • Prabhakaran D; Centre for Chronic Disease Control, New Delhi, India.
  • Rodgers A; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Salam A; The George Institute for Global Health, University of New South Wales, Hyderabad, India.
  • Selak V; Department of Epidemiology and Biostatistics, University of Auckland, Auckland, New Zealand.
  • Stepien S; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Thom S; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
  • Webster R; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
  • Lea-Laba T; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
Lancet Glob Health ; 7(10): e1359-e1366, 2019 10.
Article in En | MEDLINE | ID: mdl-31477545
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia / Oceania Language: En Journal: Lancet Glob Health Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension / Antihypertensive Agents Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Asia / Oceania Language: En Journal: Lancet Glob Health Year: 2019 Document type: Article